The evolving role of novel and next generation therapies in the management of multiple myeloma [electronic resource] : part 2 of 2, relapse refractory multiple myeloma / Paul G. Richardson.
Material type:![Film](/opac-tmpl/lib/famfamfam/VM.png)
- Evolving role of novel and next generation therapies in the management of multiple myeloma. Part 2, Relapse refractory multiple myeloma
- Antibody-drug conjugates
- Antineoplastic agents
- Multiple myeloma -- Chemotherapy
- Multiple myeloma -- Treatment
- Antibodies, Monoclonal -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Bortezomib
- Cancer Vaccines
- Drug Discovery
- elotuzumab
- Immunoconjugates -- therapeutic use
- Immunotherapy -- trends
- isatuximab
- Multiple Myeloma -- drug therapy
- Multiple Myeloma -- immunology
- Multiple Myeloma -- therapy
- Receptors, Antigen, T-Cell -- therapeutic use
- Recurrence
- T-Lymphocytes -- immunology
Animated audio-visual presentation with synchronized narration.
Title from title frames.
Contents: T-cell therapy strategies for Multiple Myeloma -- Cell-based Myeloma vaccines -- Antibody-drug conjugates -- Continuing evolution of Multiple Myeloma treatment.
Access restricted to subscribers.
Mode of access: World Wide Web.
There are no comments on this title.